BioLineRx Announces Closing of $15.4 Million Underwritten Public Offering of its American Depositary


TEL AVIV, Israel, Feb. 7, 2019 /PRNewswire/ -- BioLineRx Ltd. , a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced ... Lees verder

Bron: ANP Pers support
Geplaatst: 07 feb 2019 - 18:04